Recommendations update for the diagnosis and treatment of transthyretin variant amyloidosis (ATTRv)
Saved in:
Published in | Medicina clínica (English ed.) Vol. 163; no. 6; pp. e69 - e77 |
---|---|
Main Authors | , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Elsevier España, S.L.U
27.09.2024
|
Online Access | Get full text |
ISSN | 2387-0206 2387-0206 |
DOI | 10.1016/j.medcle.2024.04.011 |
Cover
Author | Cardoso, Márcio Neves Sevilla, Teresa Gonzalez-Lopez, Esther González-Moreno, Juan Conceiçao, Isabel Fernández-Martín, Julián Barriales-Villa, Roberto Casasnovas, Carlos Galán Dávila, Lucía Morales, Raúl Juntas López, Inés Losada Quintana, Luis F. Falcão de Campos, Catarina Muñoz-Beamud, Francisco Martínez-Vicente, Laura |
---|---|
Author_xml | – sequence: 1 givenname: Juan surname: González-Moreno fullname: González-Moreno, Juan email: jgonzalez4@hsll.es organization: Servicio de Medicina Interna, Hospital Son Llàtzer, Instituto de Investigación Sanitaria Illes Balears (idISBA), Palma de Mallorca, Spain – sequence: 2 givenname: Lucía surname: Galán Dávila fullname: Galán Dávila, Lucía organization: Servicio de Neurología, Hospital Universitario Clínico San Carlos, Madrid, Spain – sequence: 3 givenname: Esther surname: Gonzalez-Lopez fullname: Gonzalez-Lopez, Esther organization: Unidad de Cardiopatías Familiares e Insuficiencia Cardíaca, Servicio de Cardiología, Hospital Universitario Puerta de Hierro, CIBERCV, Majadahonda, Madrid, Spain – sequence: 4 givenname: Isabel surname: Conceiçao fullname: Conceiçao, Isabel organization: Serviço de Neurologia, Departamento de Neurociências, Hospital de Santa Maria (CHULN), Centro de Estudos Egas Moniz, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal – sequence: 5 givenname: Roberto surname: Barriales-Villa fullname: Barriales-Villa, Roberto organization: Familial Heart Disease Unit, Complexo Hospitalario Universitario de A Coruña (CHUAC-CIBERCV), Instituto de Investigación Biomédica de A Coruña (INIBIC), A Coruña, Spain – sequence: 6 givenname: Catarina surname: Falcão de Campos fullname: Falcão de Campos, Catarina organization: Serviço de Neurologia, Departamento de Neurociências, Hospital de Santa Maria CHULN and Lisboa, Centro de Estudos Egas Moniz, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal – sequence: 7 givenname: Márcio Neves surname: Cardoso fullname: Cardoso, Márcio Neves organization: Unidade Corino de Andrade, Departamento de Neurociências, Centro Hospitalar do Porto, Porto, Portugal – sequence: 8 givenname: Carlos surname: Casasnovas fullname: Casasnovas, Carlos organization: Neuromuscular Unit, Neurology Department, Hospital Universitari de Bellvitge, IDIBELL and CIBERER, l'Hospitalet de Llobregat, Barcelona, Spain – sequence: 9 givenname: Julián surname: Fernández-Martín fullname: Fernández-Martín, Julián organization: Internal Medicine Department, Hospital Alvaro Cunqueiro, Vigo, Pontevedra, Spain – sequence: 10 givenname: Raúl Juntas surname: Morales fullname: Morales, Raúl Juntas organization: Neuromuscular Diseases Unit, Hospital Universitari Vall d'Hebron, Barcelona, Spain – sequence: 11 givenname: Inés Losada surname: López fullname: López, Inés Losada organization: Internal Medicine Service, Hospital Son Llàtzer, Institute for Health Research Illes Balears (idISBA), Palma de Mallorca, Spain – sequence: 12 givenname: Laura surname: Martínez-Vicente fullname: Martínez-Vicente, Laura organization: Neurology Department, Hospital Universitario Clínico San Carlos, Madrid, Spain – sequence: 13 givenname: Francisco surname: Muñoz-Beamud fullname: Muñoz-Beamud, Francisco organization: Internal Medicine Department, Hospital Universitario Juan Ramón Jiménez, Huelva, Spain – sequence: 14 givenname: Luis F. surname: Quintana fullname: Quintana, Luis F. organization: Nephrology Department, Hospital Clínic, Barcelona, University of Barcelona, IDIBAPS, Barcelona, Spain – sequence: 15 givenname: Teresa surname: Sevilla fullname: Sevilla, Teresa organization: Neurology Service, Hospital Universitari i Politècnic La Fe/IISLAFE, University of Valencia, CIBERER (ERN EURO-NMD), Valencia, Spain |
BookMark | eNp9UMtqAjEUDcVCrfUPusiyXcz0JhlndFMQ6QuEgth1yONOjTiJJFPBv2-sXXRVuHAf557D4VyTgQ8eCbllUDJg9cO27NCaHZYceFVCLsYuyJCLaVMAh3rwZ74i45S2AMAaYJWAITErNKHr0FvVu-AT_drnCWkbIu03SK1Tnz4kl6jylvYRVZ-fexravCif-s0xYu88PajoVAZUd9wFZ38od_P1enW4vyGXrdolHP_2Efl4flovXovl-8vbYr4sDMuOCq0bnHFuJ6LlWlQ11-1MgdL50oqK1VrUJgMTK3ij1aye6mYqrIUKhQA9YWJEqrOuiSGliK3cR9epeJQM5CkruZXnrOQpKwm52In2eKZh9nZwGGUyDr1B6yKaXtrg_hf4BpENdw8 |
Cites_doi | 10.1136/jnnp-2014-308724 10.1016/j.jaccao.2021.06.006 10.1111/jns.12451 10.1002/ejhf.2198 10.1007/s40265-019-01129-6 10.1097/WCO.0000000000000852 10.1080/13506129.2022.2147636 10.1080/13506129.2018.1436048 10.1016/j.clinph.2020.01.022 10.1056/NEJMoa1805689 10.1055/s-0039-1688977 10.2337/dc10-1303 10.1016/j.recesp.2019.12.017 10.1080/13506129.2017.1292902 10.3390/brainsci10120989 10.1080/13506129.2019.1685487 10.1016/j.healun.2017.11.015 10.1080/13506129.2018.1556156 10.1016/j.medcli.2020.06.064 10.1093/eurheartj/ehab072 10.1161/CIRCULATIONAHA.118.035831 10.3109/13506129.2015.1015678 10.1080/13506129.2022.2091985 10.1080/13506129.2016.1272453 10.1111/ajt.17009 10.1016/S1474-4422(11)70246-0 10.1186/1750-1172-8-31 10.1016/j.jcmg.2019.07.015 10.1080/13506129.2018.1564903 10.1016/j.jacc.2017.05.053 10.1378/chest.104.2.618 |
ContentType | Journal Article |
Copyright | 2024 Elsevier España, S.L.U. |
Copyright_xml | – notice: 2024 Elsevier España, S.L.U. |
CorporateAuthor | on behalf of the A-ATTRv Working Group |
CorporateAuthor_xml | – name: on behalf of the A-ATTRv Working Group |
DBID | AAYXX CITATION |
DOI | 10.1016/j.medcle.2024.04.011 |
DatabaseName | CrossRef |
DatabaseTitle | CrossRef |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
DocumentTitleAlternate | Actualización de las recomendaciones para el diagnóstico y tratamiento de la amiloidosis por transtiretina variante (ATTRv) |
EISSN | 2387-0206 |
EndPage | e77 |
ExternalDocumentID | 10_1016_j_medcle_2024_04_011 S2387020624003863 |
GroupedDBID | --M 0R~ 457 AACTN AAEDT AAEDW AAKOC AALRI AAOAW AAXKI AAXUO ABMAC ACDAQ ACGFS ACRLP ADBBV ADCUG ADEZE AEBSH AFJKZ AFKWA AFTJW AFXIZ AGHFR AGUBO AIEXJ AIKHN AITUG AJOXV ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX AXJTR BKOJK BLXMC BNPGV EBS EFJIC FDB FIRID FYGXN KOM OAUVE ROL SSH SSZ T5K ~G- AATTM AAYWO AAYXX ACIEU AEIPS AGRNS AIIUN ANKPU APXCP CITATION EJD O9- |
ID | FETCH-LOGICAL-c1001-bb7e922d53f2b3462bf9a0ab2d5f3416b36c2b35d327ba968b783dd04e330b513 |
IEDL.DBID | AIKHN |
ISSN | 2387-0206 |
IngestDate | Tue Jul 01 02:30:27 EDT 2025 Sat Sep 28 16:01:40 EDT 2024 |
IsPeerReviewed | false |
IsScholarly | true |
Issue | 6 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c1001-bb7e922d53f2b3462bf9a0ab2d5f3416b36c2b35d327ba968b783dd04e330b513 |
ParticipantIDs | crossref_primary_10_1016_j_medcle_2024_04_011 elsevier_sciencedirect_doi_10_1016_j_medcle_2024_04_011 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2024-09-27 |
PublicationDateYYYYMMDD | 2024-09-27 |
PublicationDate_xml | – month: 09 year: 2024 text: 2024-09-27 day: 27 |
PublicationDecade | 2020 |
PublicationTitle | Medicina clínica (English ed.) |
PublicationYear | 2024 |
Publisher | Elsevier España, S.L.U |
Publisher_xml | – name: Elsevier España, S.L.U |
References | Adams, Slama (bib0120) 2020; 33 Tozza, Severi, Spina, Iovino, Aruta, Ruggiero (bib0030) 2021; 26 Maurer, Schwartz, Gundapaneni, Elliott, Merlini, Waddington-Cruz (bib0130) 2018; 379 Solomon, Adams, Kristen, Grogan, González-Duarte, Maurer (bib0110) 2019; 139 Pollak, Falk (bib0140) 1993; 104 Garcia-Pavia, Rapezzi, Adler, Arad, Basso, Brucato (bib0060) 2021; 42 Dasgupta, Rissing, Smith, Jung, Benson (bib0105) 2020; 27 Ohashi, Kodaira, Morita, Sekijima (bib0090) 2019; 26 Zhou (bib0040) 2019; 39 Kristen, Kreusser, Blum, Schönland, Frankenstein, Dösch (bib0145) 2018; 37 Conceição, Damy, Romero, Galán, Attarian, Luigetti (bib0025) 2019; 26 Ando, Coelho, Berk, Cruz, Ericzon, Ikeda (bib0020) 2013; 20 Garcia-Pavia, Bengel, Brito, Damy, Duca, Dorbala (bib0155) 2021; 23 Lamb, Deeks (bib0100) 2019; 79 Buxbaum, Dispenzieri, Eisenberg, Fändrich, Merlini, Saraiva (bib0015) 2022; 29 Tesfaye, Boulton, Dyck, Freeman, Horowitz, Kempler (bib0055) 2010; 33 López-Sainz, Hernández-Hernández, González-López, Domínguez, Restrepo-Córdoba, Cobo-Marcos (bib0065) 2021; 74 Griffin, Rosenthal, Grodin, Maurer, Grogan, Cheng (bib0150) 2021; 3 Nolano, Tozza, Caporaso, Provitera (bib0045) 2020; 10 Planté-Bordeneuve, Said (bib0035) 2011; 0 Aus dem Siepen, Hein, Bauer, Katus, Kristen (bib0135) 2017; 24 Fortanier, Delmont, Verschueren, Attarian (bib0050) 2020; 131 Phull, Sanchorawala, Connors, Doros, Ruberg, Berk (bib0095) 2018; 25 Garcia-Pavia, Domínguez, Gonzalez-Lopez (bib0075) 2021; 156 Cruz, Schmidt, Botteman, Carter, Chopra, Stewart (bib0010) 2017; 24 Sekijima (bib0005) 2015; 86 Martinez-Naharro, Treibel, Abdel-Gadir, Bulluck, Zumbo, Knight (bib0080) 2017; 70 Dorbala, Cuddy, Falk (bib0070) 2020; 13 Beirão, Malheiro, Lemos, Beirão, Costa, Torres (bib0085) 2015; 22 Adams, Tournev, Taylor, Coelho, Planté-Bordeneuve, Berk (bib0115) 2023; 30 Schmidt, Wixner, Planté-Bordeneuve, Muñoz-Beamud, Lladó, Gillmore (bib0125) 2022; 22 Aus dem Siepen (10.1016/j.medcle.2024.04.011_bib0135) 2017; 24 Planté-Bordeneuve (10.1016/j.medcle.2024.04.011_bib0035) 2011; 0 Schmidt (10.1016/j.medcle.2024.04.011_bib0125) 2022; 22 Lamb (10.1016/j.medcle.2024.04.011_bib0100) 2019; 79 Nolano (10.1016/j.medcle.2024.04.011_bib0045) 2020; 10 Garcia-Pavia (10.1016/j.medcle.2024.04.011_bib0060) 2021; 42 López-Sainz (10.1016/j.medcle.2024.04.011_bib0065) 2021; 74 Solomon (10.1016/j.medcle.2024.04.011_bib0110) 2019; 139 Beirão (10.1016/j.medcle.2024.04.011_bib0085) 2015; 22 Ohashi (10.1016/j.medcle.2024.04.011_bib0090) 2019; 26 Pollak (10.1016/j.medcle.2024.04.011_bib0140) 1993; 104 Dorbala (10.1016/j.medcle.2024.04.011_bib0070) 2020; 13 Garcia-Pavia (10.1016/j.medcle.2024.04.011_bib0075) 2021; 156 Buxbaum (10.1016/j.medcle.2024.04.011_bib0015) 2022; 29 Martinez-Naharro (10.1016/j.medcle.2024.04.011_bib0080) 2017; 70 Kristen (10.1016/j.medcle.2024.04.011_bib0145) 2018; 37 Tesfaye (10.1016/j.medcle.2024.04.011_bib0055) 2010; 33 Ando (10.1016/j.medcle.2024.04.011_bib0020) 2013; 20 Adams (10.1016/j.medcle.2024.04.011_bib0115) 2023; 30 Adams (10.1016/j.medcle.2024.04.011_bib0120) 2020; 33 Fortanier (10.1016/j.medcle.2024.04.011_bib0050) 2020; 131 Conceição (10.1016/j.medcle.2024.04.011_bib0025) 2019; 26 Griffin (10.1016/j.medcle.2024.04.011_bib0150) 2021; 3 Zhou (10.1016/j.medcle.2024.04.011_bib0040) 2019; 39 Cruz (10.1016/j.medcle.2024.04.011_bib0010) 2017; 24 Garcia-Pavia (10.1016/j.medcle.2024.04.011_bib0155) 2021; 23 Dasgupta (10.1016/j.medcle.2024.04.011_bib0105) 2020; 27 Phull (10.1016/j.medcle.2024.04.011_bib0095) 2018; 25 Maurer (10.1016/j.medcle.2024.04.011_bib0130) 2018; 379 Tozza (10.1016/j.medcle.2024.04.011_bib0030) 2021; 26 Sekijima (10.1016/j.medcle.2024.04.011_bib0005) 2015; 86 |
References_xml | – volume: 86 start-page: 1036 year: 2015 end-page: 1043 ident: bib0005 article-title: Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments publication-title: J Neurol Neurosurg Psychiatry – volume: 29 start-page: 213 year: 2022 end-page: 219 ident: bib0015 article-title: Amyloid nomenclature 2022: update, novel proteins, and recommendations by the International Society of Amyloidosis (ISA) Nomenclature Committee publication-title: Amyloid – volume: 26 start-page: 15 year: 2019 end-page: 23 ident: bib0090 article-title: Electrophysiological demyelinating features in hereditary ATTR amyloidosis publication-title: Amyloid – volume: 10 start-page: 989 year: 2020 ident: bib0045 article-title: Contribution of skin biopsy in peripheral neuropathies publication-title: Brain Sci – volume: 379 start-page: 1007 year: 2018 end-page: 1016 ident: bib0130 article-title: Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy publication-title: N Engl J Med – volume: 30 start-page: 1 year: 2023 end-page: 9 ident: bib0115 article-title: Efficacy and safety of vutrisiran for patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: a randomized clinical trial publication-title: Amyloid – volume: 22 start-page: 1646 year: 2022 end-page: 1657 ident: bib0125 article-title: Patisiran treatment in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy after liver transplantation publication-title: Am J Transplant – volume: 23 start-page: 895 year: 2021 end-page: 905 ident: bib0155 article-title: Expert consensus on the monitoring of transthyretin amyloid cardiomyopathy publication-title: Eur J Heart Fail – volume: 70 start-page: 466 year: 2017 end-page: 477 ident: bib0080 article-title: Magnetic resonance in transthyretin cardiac amyloidosis publication-title: J Am Coll Cardiol – volume: 0 start-page: 1086 year: 2011 end-page: 1097 ident: bib0035 article-title: Familial amyloid polyneuropathy publication-title: Lancet Neurol – volume: 33 start-page: 2285 year: 2010 end-page: 2293 ident: bib0055 article-title: Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments publication-title: Diabetes Care – volume: 79 start-page: 863 year: 2019 end-page: 874 ident: bib0100 article-title: Tafamidis: a review in transthyretin amyloidosis with polyneuropathy publication-title: Drugs – volume: 26 start-page: 155 year: 2021 end-page: 159 ident: bib0030 article-title: The neuropathy in hereditary transthyretin amyloidosis: a narrative review publication-title: J Peripher Nerv Syst – volume: 156 start-page: 126 year: 2021 end-page: 134 ident: bib0075 article-title: Transthyretin amyloid cardiomyopathy publication-title: Med Clin (Barc) – volume: 37 start-page: 611 year: 2018 end-page: 618 ident: bib0145 article-title: Improved outcomes after heart transplantation for cardiac amyloidosis in the modern era publication-title: J Heart Lung Transplant – volume: 104 start-page: 618 year: 1993 end-page: 620 ident: bib0140 article-title: Left ventricular systolic dysfunction precipitated by verapamil in cardiac amyloidosis publication-title: Chest – volume: 22 start-page: 117 year: 2015 end-page: 122 ident: bib0085 article-title: Ophthalmological manifestations in hereditary transthyretin (ATTR V30M) carriers: a review of 513 cases publication-title: Amyloid – volume: 26 start-page: 3 year: 2019 end-page: 9 ident: bib0025 article-title: Early diagnosis of ATTR amyloidosis through targeted follow-up of identified carriers of TTR gene mutations publication-title: Amyloid – volume: 13 start-page: 1368 year: 2020 end-page: 1383 ident: bib0070 article-title: How to image cardiac amyloidosis: a practical approach publication-title: JACC Cardiovasc Imaging – volume: 25 start-page: 62 year: 2018 end-page: 67 ident: bib0095 article-title: Monoclonal gammopathy of undetermined significance in systemic transthyretin amyloidosis (ATTR) publication-title: Amyloid – volume: 24 start-page: 132 year: 2017 end-page: 133 ident: bib0135 article-title: Standard heart failure medication in cardiac transthyretin amyloidosis: useful or harmful? publication-title: Amyloid – volume: 24 start-page: 109 year: 2017 end-page: 110 ident: bib0010 article-title: Epidemiological and clinical characteristics of persons with transthyretin hereditary amyloid polyneuropathy: a global synthesis of 532 cases publication-title: Amyloid – volume: 39 start-page: 570 year: 2019 end-page: 577 ident: bib0040 article-title: Small fiber neuropathy publication-title: Semin Neurol – volume: 131 start-page: 1129 year: 2020 end-page: 1133 ident: bib0050 article-title: Quantitative sudomotor test helps differentiate transthyretin familial amyloid polyneuropathy from chronic inflammatory demyelinating polyneuropathy publication-title: Clin Neurophysiol – volume: 74 start-page: 149 year: 2021 end-page: 158 ident: bib0065 article-title: Perfil clínico y evolución de la amiloidosis cardiaca en un centro español de referencia publication-title: Rev Española Cardiol – volume: 3 start-page: 488 year: 2021 end-page: 505 ident: bib0150 article-title: ATTR amyloidosis: current and emerging management strategies: JACC: cardiooncology state-of-the-art review publication-title: JACC CardioOncol – volume: 33 start-page: 553 year: 2020 end-page: 561 ident: bib0120 article-title: Hereditary transthyretin amyloidosis: current treatment publication-title: Curr Opin Neurol – volume: 42 start-page: 1554 year: 2021 end-page: 1568 ident: bib0060 article-title: Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases publication-title: Eur Heart J – volume: 139 start-page: 431 year: 2019 end-page: 443 ident: bib0110 article-title: Effects of patisiran, an RNA interference therapeutic, on cardiac parameters in patients with hereditary transthyretin-mediated amyloidosis publication-title: Circulation – volume: 20 start-page: 31 year: 2013 ident: bib0020 article-title: Guideline of transthyretin-related hereditary amyloidosis for clinicians publication-title: Orphanet J Rare Dis – volume: 27 start-page: 52 year: 2020 end-page: 58 ident: bib0105 article-title: Inotersen therapy of transthyretin amyloid cardiomyopathy publication-title: Amyloid – volume: 86 start-page: 1036 year: 2015 ident: 10.1016/j.medcle.2024.04.011_bib0005 article-title: Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments publication-title: J Neurol Neurosurg Psychiatry doi: 10.1136/jnnp-2014-308724 – volume: 3 start-page: 488 year: 2021 ident: 10.1016/j.medcle.2024.04.011_bib0150 article-title: ATTR amyloidosis: current and emerging management strategies: JACC: cardiooncology state-of-the-art review publication-title: JACC CardioOncol doi: 10.1016/j.jaccao.2021.06.006 – volume: 26 start-page: 155 year: 2021 ident: 10.1016/j.medcle.2024.04.011_bib0030 article-title: The neuropathy in hereditary transthyretin amyloidosis: a narrative review publication-title: J Peripher Nerv Syst doi: 10.1111/jns.12451 – volume: 23 start-page: 895 year: 2021 ident: 10.1016/j.medcle.2024.04.011_bib0155 article-title: Expert consensus on the monitoring of transthyretin amyloid cardiomyopathy publication-title: Eur J Heart Fail doi: 10.1002/ejhf.2198 – volume: 79 start-page: 863 year: 2019 ident: 10.1016/j.medcle.2024.04.011_bib0100 article-title: Tafamidis: a review in transthyretin amyloidosis with polyneuropathy publication-title: Drugs doi: 10.1007/s40265-019-01129-6 – volume: 33 start-page: 553 year: 2020 ident: 10.1016/j.medcle.2024.04.011_bib0120 article-title: Hereditary transthyretin amyloidosis: current treatment publication-title: Curr Opin Neurol doi: 10.1097/WCO.0000000000000852 – volume: 29 start-page: 213 year: 2022 ident: 10.1016/j.medcle.2024.04.011_bib0015 article-title: Amyloid nomenclature 2022: update, novel proteins, and recommendations by the International Society of Amyloidosis (ISA) Nomenclature Committee publication-title: Amyloid doi: 10.1080/13506129.2022.2147636 – volume: 25 start-page: 62 year: 2018 ident: 10.1016/j.medcle.2024.04.011_bib0095 article-title: Monoclonal gammopathy of undetermined significance in systemic transthyretin amyloidosis (ATTR) publication-title: Amyloid doi: 10.1080/13506129.2018.1436048 – volume: 131 start-page: 1129 year: 2020 ident: 10.1016/j.medcle.2024.04.011_bib0050 article-title: Quantitative sudomotor test helps differentiate transthyretin familial amyloid polyneuropathy from chronic inflammatory demyelinating polyneuropathy publication-title: Clin Neurophysiol doi: 10.1016/j.clinph.2020.01.022 – volume: 379 start-page: 1007 year: 2018 ident: 10.1016/j.medcle.2024.04.011_bib0130 article-title: Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy publication-title: N Engl J Med doi: 10.1056/NEJMoa1805689 – volume: 39 start-page: 570 year: 2019 ident: 10.1016/j.medcle.2024.04.011_bib0040 article-title: Small fiber neuropathy publication-title: Semin Neurol doi: 10.1055/s-0039-1688977 – volume: 33 start-page: 2285 year: 2010 ident: 10.1016/j.medcle.2024.04.011_bib0055 article-title: Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments publication-title: Diabetes Care doi: 10.2337/dc10-1303 – volume: 74 start-page: 149 year: 2021 ident: 10.1016/j.medcle.2024.04.011_bib0065 article-title: Perfil clínico y evolución de la amiloidosis cardiaca en un centro español de referencia publication-title: Rev Española Cardiol doi: 10.1016/j.recesp.2019.12.017 – volume: 24 start-page: 109 year: 2017 ident: 10.1016/j.medcle.2024.04.011_bib0010 article-title: Epidemiological and clinical characteristics of persons with transthyretin hereditary amyloid polyneuropathy: a global synthesis of 532 cases publication-title: Amyloid doi: 10.1080/13506129.2017.1292902 – volume: 10 start-page: 989 year: 2020 ident: 10.1016/j.medcle.2024.04.011_bib0045 article-title: Contribution of skin biopsy in peripheral neuropathies publication-title: Brain Sci doi: 10.3390/brainsci10120989 – volume: 27 start-page: 52 year: 2020 ident: 10.1016/j.medcle.2024.04.011_bib0105 article-title: Inotersen therapy of transthyretin amyloid cardiomyopathy publication-title: Amyloid doi: 10.1080/13506129.2019.1685487 – volume: 37 start-page: 611 year: 2018 ident: 10.1016/j.medcle.2024.04.011_bib0145 article-title: Improved outcomes after heart transplantation for cardiac amyloidosis in the modern era publication-title: J Heart Lung Transplant doi: 10.1016/j.healun.2017.11.015 – volume: 26 start-page: 3 year: 2019 ident: 10.1016/j.medcle.2024.04.011_bib0025 article-title: Early diagnosis of ATTR amyloidosis through targeted follow-up of identified carriers of TTR gene mutations publication-title: Amyloid doi: 10.1080/13506129.2018.1556156 – volume: 156 start-page: 126 year: 2021 ident: 10.1016/j.medcle.2024.04.011_bib0075 article-title: Transthyretin amyloid cardiomyopathy publication-title: Med Clin (Barc) doi: 10.1016/j.medcli.2020.06.064 – volume: 42 start-page: 1554 year: 2021 ident: 10.1016/j.medcle.2024.04.011_bib0060 article-title: Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases publication-title: Eur Heart J doi: 10.1093/eurheartj/ehab072 – volume: 139 start-page: 431 year: 2019 ident: 10.1016/j.medcle.2024.04.011_bib0110 article-title: Effects of patisiran, an RNA interference therapeutic, on cardiac parameters in patients with hereditary transthyretin-mediated amyloidosis publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.118.035831 – volume: 22 start-page: 117 year: 2015 ident: 10.1016/j.medcle.2024.04.011_bib0085 article-title: Ophthalmological manifestations in hereditary transthyretin (ATTR V30M) carriers: a review of 513 cases publication-title: Amyloid doi: 10.3109/13506129.2015.1015678 – volume: 30 start-page: 1 year: 2023 ident: 10.1016/j.medcle.2024.04.011_bib0115 article-title: Efficacy and safety of vutrisiran for patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: a randomized clinical trial publication-title: Amyloid doi: 10.1080/13506129.2022.2091985 – volume: 24 start-page: 132 year: 2017 ident: 10.1016/j.medcle.2024.04.011_bib0135 article-title: Standard heart failure medication in cardiac transthyretin amyloidosis: useful or harmful? publication-title: Amyloid doi: 10.1080/13506129.2016.1272453 – volume: 22 start-page: 1646 year: 2022 ident: 10.1016/j.medcle.2024.04.011_bib0125 article-title: Patisiran treatment in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy after liver transplantation publication-title: Am J Transplant doi: 10.1111/ajt.17009 – volume: 0 start-page: 1086 year: 2011 ident: 10.1016/j.medcle.2024.04.011_bib0035 article-title: Familial amyloid polyneuropathy publication-title: Lancet Neurol doi: 10.1016/S1474-4422(11)70246-0 – volume: 20 start-page: 31 year: 2013 ident: 10.1016/j.medcle.2024.04.011_bib0020 article-title: Guideline of transthyretin-related hereditary amyloidosis for clinicians publication-title: Orphanet J Rare Dis doi: 10.1186/1750-1172-8-31 – volume: 13 start-page: 1368 year: 2020 ident: 10.1016/j.medcle.2024.04.011_bib0070 article-title: How to image cardiac amyloidosis: a practical approach publication-title: JACC Cardiovasc Imaging doi: 10.1016/j.jcmg.2019.07.015 – volume: 26 start-page: 15 year: 2019 ident: 10.1016/j.medcle.2024.04.011_bib0090 article-title: Electrophysiological demyelinating features in hereditary ATTR amyloidosis publication-title: Amyloid doi: 10.1080/13506129.2018.1564903 – volume: 70 start-page: 466 year: 2017 ident: 10.1016/j.medcle.2024.04.011_bib0080 article-title: Magnetic resonance in transthyretin cardiac amyloidosis publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2017.05.053 – volume: 104 start-page: 618 year: 1993 ident: 10.1016/j.medcle.2024.04.011_bib0140 article-title: Left ventricular systolic dysfunction precipitated by verapamil in cardiac amyloidosis publication-title: Chest doi: 10.1378/chest.104.2.618 |
SSID | ssj0001701430 |
Score | 2.272962 |
SourceID | crossref elsevier |
SourceType | Index Database Publisher |
StartPage | e69 |
Title | Recommendations update for the diagnosis and treatment of transthyretin variant amyloidosis (ATTRv) |
URI | https://dx.doi.org/10.1016/j.medcle.2024.04.011 |
Volume | 163 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La8MwDBZdC2OXsSfrXviww3YITeLETo-lrHQb7WFrobdgxw5krGlZH79_Uh57wNhhkIsdZIIc65OSTxLATaSMMgiMjhWhdAKeeo5Ow8hRRLzRHrfCUnLyaCyG0-BxFs4a0K9zYYhWWdn-0qYX1rqa6VTa7CyzrPOCYCPR2RHEguSR4DvQ8hHtoya0eg9Pw_HXpxZJRezcos0cHimSqZPoCqYXMSHfqGSmHxRlTz3vd5D6BjyDA9ivPEbWKx_qEBo2P4LdUfVP_BgSiiDnc1t1R1qxzZKieIbeKEPvjpmSTJetmMoN-ySWs0WKAwQq3CnKZMzZFsNm1DNTcwziM1OI3PYmk-ft3QlMB_eT_tCpWic4CRVVcrSWtuv7JuSpr3kgfJ12las0zqSIW0JzkeCN0HBfatUVkZYRN8YNLOeuDj1-Cs18kdszYGkSGRuJNEiot5XBlQJqW5WEGPtQl442OLWu4mVZISOuqWOvcanbmHQbu3h5XhtkrdD4x07HaMT_lDz_t-QF7NGIeB6-vITm-n1jr9CZWOvr6mX5AJmDyN8 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8NAEB5qC-pFfGJ97sGDHkKTbLJJj6VYUvs4aAq9hWx2AxWbFvv4_c7k4QPEg5BLdpkQZnfnkXwzH8CdH6tYoWM0tHA9w-GpZcjU9Y2YgDfS4lpoKk4ejUUwcZ6m7rQG3aoWhmCVpe0vbHpurcuRVqnN1nI2a72gs_Ew2BGEguS-4DvQcIjUug6NTn8QjL8-tXjUxM7MaebwSJFMVUSXI70ICflGLTNtJ297alm_O6lvjqd3CAdlxMg6xUsdQU1nx7A7Kv-Jn0BCGeR8rkt2pBXbLCmLZxiNMozumCrAdLMVizPFPoHlbJHiDToqXCmqZMzYFtNm1DOL55jEz1Quct8Jw-ftwylMeo9hNzBK6gQjoaZKhpSebtu2cnlqS-4IW6bt2IwljqTot4TkIsEJV3Hbk3Fb-NLzuVKmozk3pWvxM6hni0yfA0sTX2lfpE5C3FYKn-QQbVXiYu5DLB1NMCpdRcuiQ0ZUQcdeo0K3Eek2MvGyrCZ4lUKjHysdoRH_U_Li35K3sBeEo2E07I8Hl7BPM4T5sL0rqK_fN_oaA4u1vCk3zgcWZsvD |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Recommendations+update+for+the+diagnosis+and+treatment+of+transthyretin+variant+amyloidosis+%28ATTRv%29&rft.jtitle=Medicina+cl%C3%ADnica+%28English+ed.%29&rft.au=Gonz%C3%A1lez-Moreno%2C+Juan&rft.au=Gal%C3%A1n+D%C3%A1vila%2C+Luc%C3%ADa&rft.au=Gonzalez-Lopez%2C+Esther&rft.au=Concei%C3%A7ao%2C+Isabel&rft.date=2024-09-27&rft.pub=Elsevier+Espa%C3%B1a%2C+S.L.U&rft.issn=2387-0206&rft.eissn=2387-0206&rft.volume=163&rft.issue=6&rft.spage=e69&rft.epage=e77&rft_id=info:doi/10.1016%2Fj.medcle.2024.04.011&rft.externalDocID=S2387020624003863 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2387-0206&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2387-0206&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2387-0206&client=summon |